Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome

by Lawrence B. Afrin, Leonard B. Weinstock, Gerhard J. Molderings
Published 2020-11-01

Case Report: Treatment of systemic mastocytosis with sunitinib [version 1; referees: 2 approved]

by Gerhard J. Molderings, Lawrence B. Afrin, Hans-Jörg Hertfelder, Stefan Brettner
Published 2017-12-01

Familial occurrence of systemic mast cell activation disease.

by Gerhard J Molderings, Britta Haenisch, Manuela Bogdanow, Rolf Fimmers, Markus M Nöthen
Published 2013-01-01

Correction : Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome

by Tobias Jürgen Schmidt, Julia Sellin, Gerhard J. Molderings, Rupert Conrad, Martin Mücke
Published 2023-02-01

Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome

by Tobias Jürgen Schmidt, Julia Sellin, Gerhard J. Molderings, Rupert Conrad, Martin Mücke
Published 2022-07-01

Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA [version 1; referees: 2 approved]

by Gerhard J. Molderings, Thomas Zienkiewicz, Jürgen Homann, Markus Menzen, Lawrence B. Afrin
Published 2017-10-01

Determination of plasma heparin level improves identification of systemic mast cell activation disease.

by Milda Vysniauskaite, Hans-Jörg Hertfelder, Johannes Oldenburg, Peter Dreßen, Stefan Brettner, Jürgen Homann, Gerhard J Molderings
Published 2015-01-01

Mast cell activation symptoms are prevalent in Long-COVID

by Leonard B. Weinstock, Jill B. Brook, Arthur S. Walters, Ashleigh Goris, Lawrence B. Afrin, Gerhard J. Molderings
Published 2021-11-01

Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis

by Holger Seidel, Hans-Jörg Hertfelder, Johannes Oldenburg, Johannes P. Kruppenbacher, Lawrence B. Afrin, Gerhard J. Molderings
Published 2021-08-01